Journal article
Massed versus standard prolonged exposure for posttraumatic stress disorder in Australian military and veteran populations (RESTORE trial): Study protocol for a non-inferiority randomized controlled trial
L Dell, AM Sbisa, M O'Donnell, PW Tuerk, R Bryant, S Hodson, D Morton, M Battersby, A Forbes, D Forbes
Contemporary Clinical Trials | ELSEVIER SCIENCE INC | Published : 2021
Abstract
Posttraumatic stress disorder (PTSD) can be a severe problem, affecting veterans and military personnel at higher rates than the general community. First-line treatment for PTSD, prolonged exposure (PE), is typically delivered weekly for 10–12 weeks, however this duration can pose a barrier to accessing and completing the treatment, particularly for current serving military. This paper presents the RESTORE trial protocol, the first randomized controlled trial of massed PE therapy outside of the United States and by an independent research group. One hundred and thirty-five Australian Defence Force members and veterans (18–80 years) who meet criteria for PTSD related to a military trauma will..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work is supported by a National Health and Medical Research Council Partnership grant (APP1110932) . Partner funding and in-kind support is also provided by the partner organizations, the ADF, DVA and Open Arms.